Treace Medical Concepts, Inc. (TMCI)
4.63
-0.18
(-3.74%)
USD |
NASDAQ |
Sep 08, 16:00
4.645
+0.02
(+0.32%)
After-Hours: 20:00
Treace Medical Concepts Profit Margin (Quarterly) : -34.98% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.98% |
| March 31, 2026 | -38.05% |
| December 31, 2025 | -15.03% |
| September 30, 2025 | -32.44% |
| June 30, 2025 | -36.71% |
| March 31, 2025 | -30.29% |
| December 31, 2024 | -0.73% |
| September 30, 2024 | -34.07% |
| June 30, 2024 | -47.70% |
| March 31, 2024 | -36.54% |
| December 31, 2023 | -10.10% |
| September 30, 2023 | -42.99% |
| June 30, 2023 | -29.25% |
| March 31, 2023 | -31.89% |
| December 31, 2022 | -8.86% |
| Date | Value |
|---|---|
| September 30, 2022 | -36.71% |
| June 30, 2022 | -57.51% |
| March 31, 2022 | -31.11% |
| December 31, 2021 | -19.79% |
| September 30, 2021 | -29.69% |
| June 30, 2021 | -24.61% |
| March 31, 2021 | -13.00% |
| December 31, 2020 | 10.64% |
| September 30, 2020 | -18.61% |
| June 30, 2020 | -25.49% |
| March 31, 2020 | -14.28% |
| December 31, 2019 | 11.26% |
| September 30, 2019 | -30.33% |
| June 30, 2019 | -19.79% |
| March 31, 2019 | -32.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tactile Systems Technology, Inc. | 9.08% |
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -13.17% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.01% |
| Return on Assets | -31.04% |
| Return on Invested Capital | -38.35% |
| Gross Profit Margin (Quarterly) | 78.47% |
| Operating Margin (Quarterly) | -32.96% |
| Return on Net Operating Assets | -45.09% |